Hyperchylomicronemia clinical trials

Explore recruiting hyperchylomicronemia clinical trials.

Recruiting hyperchylomicronemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hyperchylomicronemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ISIS 678354-CS5: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ISIS 678354 Administered Subcutaneously to Patients with Severe Hypertriglyceridemia.

Finland, Germany, Poland, Sweden, Slovakia, Hungary +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

ISIS 678354-CS6 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients with Severe Hypertriglyceridemia

France, Italy, Hungary, Belgium, Poland, Slovakia +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

ISIS 678354-CS7: An Open-Label Study of AKCEA-APOCIII-LRX Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen (ISIS 304801)

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

ISIS 678354-CS13: An Open-Label Extension Study of AKCEA-APOCIII-LRX Administered Subcutaneously to Patients with Familial Chylomicronemia Syndrome (FCS)

Sweden, Spain, Slovakia, Netherlands, Portugal, Italy +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hyperchylomicronemia trials by city

Hyperchylomicronemia in Toronto Hyperchylomicronemia in Vancouver Hyperchylomicronemia in Montreal Hyperchylomicronemia in Calgary Hyperchylomicronemia in Edmonton Hyperchylomicronemia in Ottawa Hyperchylomicronemia in Winnipeg Hyperchylomicronemia in Quebec City Hyperchylomicronemia in Hamilton Hyperchylomicronemia in Kitchener Hyperchylomicronemia in London Hyperchylomicronemia in Halifax Hyperchylomicronemia in New York Hyperchylomicronemia in Los Angeles Hyperchylomicronemia in Chicago Hyperchylomicronemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease